Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ambrx Biopharma Inc | 0 | 16,688,636 | +16,688,636 | $0 | $237.65M | 46.64% | +$237.65M |
| TG Therapeutics, Inc.(TGTX) | 0 | 4,046,598 | +4,046,598 | $0 | $69.12M | 13.57% | +$69.12M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 1,039,289 | +1,039,289 | $0 | $62.76M | 12.32% | +$62.76M |
| Cytokinetics, Incorporated(CYTK) | 0 | 600,000 | +600,000 | $0 | $50.09M | 9.83% | +$50.09M |
| Keros Therapeutics, Inc.(KROS) | 0 | 1,060,427 | +1,060,427 | $0 | $42.16M | 8.28% | +$42.16M |
| Vaxcyte, Inc.(PCVX) | 0 | 579,959 | +579,959 | $0 | $36.42M | 7.15% | +$36.42M |
| Springworks Therapeutics Inc | 0 | 192,734 | +192,734 | $0 | $7.03M | 1.38% | +$7.03M |
| Nuvalent Inc | 0 | 57,698 | +57,698 | $0 | $4.25M | 0.83% | +$4.25M |
| AMBRX BIOPHARMA INCSPONSORED ADS | 16,688,636 | 0 | -16,688,636 | $191.92M | $0 | — | -$191.92M |
| ARGENX SESPONSORED ADR(ARGX) | 45,615 | 0 | -45,615 | $22.43M | $0 | — | -$22.43M |
| IMMUNOVANT INCCOM(IMVT) | 1,818,371 | 0 | -1,818,371 | $69.81M | $0 | — | -$69.81M |